The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function
NCT06587386
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Motion Sickness
Interventions
DRUG:
First patient Bupivacaine liposome and next patient Bupivacaine liposome
Sponsor
Affiliated Hospital of Jiaxing University